This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
CiplaMed 2.0 leverages advanced analytics and automation
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
CMOs showed an increasing reluctance to take on debt in 2022
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Approval to dramatically change CAR-T therapies landscape
Subscribe To Our Newsletter & Stay Updated
